CymitQuimica logo

CAS 1166227-08-2

:

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produtos.
  • 1,2-Pyrrolidinedicarboxamide, N1-[2-(1,1-dimethylethyl)-4'-methyl[4,5'-bithiazol]-2'-yl]-, (2S)-

    CAS:
    Fórmula:C17H23N5O2S2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:393.5268

    Ref: IN-DA000CVY

    1mg
    75,00€
    5mg
    131,00€
    10mg
    206,00€
    50mg
    276,00€
  • (S)-N1-(2-(Tert-Butyl)-4'-Methyl-[4,5'-Bithiazol]-2'-Yl)Pyrrolidine-1,2-Dicarboxamide

    CAS:
    (S)-N1-(2-(Tert-Butyl)-4'-Methyl-[4,5'-Bithiazol]-2'-Yl)Pyrrolidine-1,2-Dicarboxamide
    Pureza:98%
    Peso molecular:393.53g/mol

    Ref: 54-OR1023359

    25mg
    190,00€
    50mg
    310,00€
    100mg
    505,00€
    250mg
    944,00€
  • A66

    CAS:
    A66
    Pureza:≥95%
    Peso molecular:393.53g/mol

    Ref: 54-BUP12920

    5mg
    74,00€
    10mg
    116,00€
    25mg
    211,00€
    50mg
    351,00€
    100mg
    509,00€
    200mg
    703,00€
  • A66

    CAS:
    A66 is a specific and effective p110α inhibitor(IC50=32 nM).
    Fórmula:C17H23N5O2S2
    Pureza:99.51% - ≥95%
    Cor e Forma:Solid
    Peso molecular:393.53

    Ref: TM-T2418

    2mg
    34,00€
    5mg
    52,00€
    10mg
    79,00€
    25mg
    137,00€
    50mg
    234,00€
    100mg
    344,00€
    200mg
    485,00€
    1mL*10mM (DMSO)
    52,00€
  • A 66

    CAS:

    Specific inhibitor of the phosphoinositide 3-kinase (PI3K) alpha subunit with IC50 of 32 nM. In heart muscle it negatively regulates hypertrophic growth, causes increase in late sodium current and leads to arrhythmias. In tumours it inhibits the p110α subunit of PI3K and blocks growth factor signalling resulting in reduced tumour growth.

    Fórmula:C17H23N5O2S2
    Pureza:Min. 95%
    Cor e Forma:Solid
    Peso molecular:393.53 g/mol

    Ref: 3D-BA41291

    10mg
    172,00€
    50mg
    486,00€
  • A66

    CAS:
    Pureza:≥98%
    Peso molecular:393.129

    Ref: 10-F861536

    1mg
    71,00€
    5mg
    A consultar
    10mg
    A consultar
    50mg
    A consultar